nodes	percent_of_prediction	percent_of_DWPC	metapath
Amiloride—SLC22A1—hematologic cancer	0.287	1	CbGaD
Amiloride—SLC22A2—Daunorubicin—hematologic cancer	0.0463	0.155	CbGbCtD
Amiloride—SLC22A2—Cytarabine—hematologic cancer	0.0408	0.137	CbGbCtD
Amiloride—SLC22A2—Cladribine—hematologic cancer	0.0385	0.129	CbGbCtD
Amiloride—SLC22A1—Cytarabine—hematologic cancer	0.0355	0.119	CbGbCtD
Amiloride—SLC22A2—Imatinib—hematologic cancer	0.0354	0.119	CbGbCtD
Amiloride—SLC22A1—Cladribine—hematologic cancer	0.0335	0.112	CbGbCtD
Amiloride—SLC22A1—Imatinib—hematologic cancer	0.0308	0.103	CbGbCtD
Amiloride—SLC22A2—Vinblastine—hematologic cancer	0.0197	0.0659	CbGbCtD
Amiloride—SLC22A2—Cisplatin—hematologic cancer	0.018	0.0604	CbGbCtD
Amiloride—AOC1—hematopoietic system—hematologic cancer	0.00368	0.0529	CbGeAlD
Amiloride—SLC9A1—hematopoietic system—hematologic cancer	0.00352	0.0507	CbGeAlD
Amiloride—PLAU—hematopoietic system—hematologic cancer	0.00334	0.048	CbGeAlD
Amiloride—SCNN1D—gonad—hematologic cancer	0.00285	0.041	CbGeAlD
Amiloride—AOC1—blood—hematologic cancer	0.00244	0.0351	CbGeAlD
Amiloride—SCNN1B—gonad—hematologic cancer	0.00241	0.0346	CbGeAlD
Amiloride—AOC1—bone marrow—hematologic cancer	0.00236	0.0339	CbGeAlD
Amiloride—SLC9A1—blood—hematologic cancer	0.00233	0.0336	CbGeAlD
Amiloride—SLC9A1—bone marrow—hematologic cancer	0.00226	0.0325	CbGeAlD
Amiloride—PLAU—blood—hematologic cancer	0.00221	0.0318	CbGeAlD
Amiloride—SCNN1G—lung—hematologic cancer	0.00218	0.0313	CbGeAlD
Amiloride—SCNN1D—lung—hematologic cancer	0.00218	0.0313	CbGeAlD
Amiloride—PLAU—bone marrow—hematologic cancer	0.00214	0.0308	CbGeAlD
Amiloride—SCNN1D—testis—hematologic cancer	0.00205	0.0295	CbGeAlD
Amiloride—SLC9A1—lung—hematologic cancer	0.00205	0.0294	CbGeAlD
Amiloride—AOC1—testis—hematologic cancer	0.00202	0.029	CbGeAlD
Amiloride—ASIC1—testis—hematologic cancer	0.00202	0.029	CbGeAlD
Amiloride—PLAU—lung—hematologic cancer	0.00194	0.0279	CbGeAlD
Amiloride—SCNN1A—blood—hematologic cancer	0.00194	0.0279	CbGeAlD
Amiloride—SLC9A1—testis—hematologic cancer	0.00193	0.0278	CbGeAlD
Amiloride—SCNN1B—lung—hematologic cancer	0.00184	0.0265	CbGeAlD
Amiloride—PLAU—testis—hematologic cancer	0.00183	0.0263	CbGeAlD
Amiloride—SCNN1B—testis—hematologic cancer	0.00173	0.025	CbGeAlD
Amiloride—SCNN1A—lung—hematologic cancer	0.0017	0.0244	CbGeAlD
Amiloride—SCNN1A—testis—hematologic cancer	0.0016	0.0231	CbGeAlD
Amiloride—SCNN1D—lymph node—hematologic cancer	0.00149	0.0214	CbGeAlD
Amiloride—ASIC1—lymph node—hematologic cancer	0.00146	0.021	CbGeAlD
Amiloride—AOC1—lymph node—hematologic cancer	0.00146	0.021	CbGeAlD
Amiloride—SLC9A1—lymph node—hematologic cancer	0.0014	0.0201	CbGeAlD
Amiloride—PLAU—lymph node—hematologic cancer	0.00133	0.0191	CbGeAlD
Amiloride—SCNN1B—lymph node—hematologic cancer	0.00126	0.0181	CbGeAlD
Amiloride—SCNN1A—lymph node—hematologic cancer	0.00116	0.0167	CbGeAlD
Amiloride—SLC22A4—blood—hematologic cancer	0.000776	0.0112	CbGeAlD
Amiloride—SLC22A4—bone marrow—hematologic cancer	0.000751	0.0108	CbGeAlD
Amiloride—SLC22A1—blood—hematologic cancer	0.000739	0.0106	CbGeAlD
Amiloride—SLC22A4—lung—hematologic cancer	0.000681	0.00979	CbGeAlD
Amiloride—SLC22A4—lymph node—hematologic cancer	0.000465	0.0067	CbGeAlD
Amiloride—PLAU—Betamethasone—Dexamethasone—hematologic cancer	0.000327	0.131	CbGdCrCtD
Amiloride—PLAU—Dexamethasone—Betamethasone—hematologic cancer	0.000327	0.131	CbGdCrCtD
Amiloride—PLAU—Betamethasone—Triamcinolone—hematologic cancer	0.00032	0.128	CbGdCrCtD
Amiloride—PLAU—Dexamethasone—Triamcinolone—hematologic cancer	0.00032	0.128	CbGdCrCtD
Amiloride—PLAU—Dexamethasone—Prednisone—hematologic cancer	0.000304	0.122	CbGdCrCtD
Amiloride—PLAU—Betamethasone—Prednisone—hematologic cancer	0.000304	0.122	CbGdCrCtD
Amiloride—PLAU—Dexamethasone—Prednisolone—hematologic cancer	0.000296	0.119	CbGdCrCtD
Amiloride—PLAU—Betamethasone—Prednisolone—hematologic cancer	0.000296	0.119	CbGdCrCtD
Amiloride—Headache—Carmustine—hematologic cancer	4.29e-05	0.000218	CcSEcCtD
Amiloride—Shock—Dexamethasone—hematologic cancer	4.29e-05	0.000218	CcSEcCtD
Amiloride—Shock—Betamethasone—hematologic cancer	4.29e-05	0.000218	CcSEcCtD
Amiloride—Dyspnoea—Triamcinolone—hematologic cancer	4.29e-05	0.000218	CcSEcCtD
Amiloride—Rash—Alitretinoin—hematologic cancer	4.28e-05	0.000217	CcSEcCtD
Amiloride—Dermatitis—Alitretinoin—hematologic cancer	4.28e-05	0.000217	CcSEcCtD
Amiloride—Vomiting—Ifosfamide—hematologic cancer	4.27e-05	0.000217	CcSEcCtD
Amiloride—Bradycardia—Epirubicin—hematologic cancer	4.26e-05	0.000216	CcSEcCtD
Amiloride—Headache—Alitretinoin—hematologic cancer	4.25e-05	0.000216	CcSEcCtD
Amiloride—Diarrhoea—Gemcitabine—hematologic cancer	4.25e-05	0.000216	CcSEcCtD
Amiloride—Nausea—Thalidomide—hematologic cancer	4.24e-05	0.000215	CcSEcCtD
Amiloride—Dyspepsia—Triamcinolone—hematologic cancer	4.23e-05	0.000215	CcSEcCtD
Amiloride—Rash—Ifosfamide—hematologic cancer	4.23e-05	0.000215	CcSEcCtD
Amiloride—Dermatitis—Ifosfamide—hematologic cancer	4.23e-05	0.000215	CcSEcCtD
Amiloride—Dizziness—Irinotecan—hematologic cancer	4.21e-05	0.000214	CcSEcCtD
Amiloride—Haemoglobin—Epirubicin—hematologic cancer	4.2e-05	0.000214	CcSEcCtD
Amiloride—Jaundice—Doxorubicin—hematologic cancer	4.2e-05	0.000213	CcSEcCtD
Amiloride—Abdominal pain—Etoposide—hematologic cancer	4.19e-05	0.000213	CcSEcCtD
Amiloride—Vertigo—Prednisone—hematologic cancer	4.18e-05	0.000212	CcSEcCtD
Amiloride—Haemorrhage—Epirubicin—hematologic cancer	4.18e-05	0.000212	CcSEcCtD
Amiloride—Tinnitus—Methotrexate—hematologic cancer	4.17e-05	0.000212	CcSEcCtD
Amiloride—Vomiting—Vincristine—hematologic cancer	4.16e-05	0.000211	CcSEcCtD
Amiloride—Anorexia—Betamethasone—hematologic cancer	4.16e-05	0.000211	CcSEcCtD
Amiloride—Anorexia—Dexamethasone—hematologic cancer	4.16e-05	0.000211	CcSEcCtD
Amiloride—Asthenia—Cisplatin—hematologic cancer	4.15e-05	0.000211	CcSEcCtD
Amiloride—Fatigue—Triamcinolone—hematologic cancer	4.14e-05	0.000211	CcSEcCtD
Amiloride—Rash—Vincristine—hematologic cancer	4.13e-05	0.00021	CcSEcCtD
Amiloride—Dermatitis—Vincristine—hematologic cancer	4.12e-05	0.000209	CcSEcCtD
Amiloride—Pain—Triamcinolone—hematologic cancer	4.11e-05	0.000209	CcSEcCtD
Amiloride—Headache—Vincristine—hematologic cancer	4.1e-05	0.000208	CcSEcCtD
Amiloride—Nausea—Carmustine—hematologic cancer	4.07e-05	0.000207	CcSEcCtD
Amiloride—Vomiting—Mitoxantrone—hematologic cancer	4.05e-05	0.000206	CcSEcCtD
Amiloride—Vomiting—Irinotecan—hematologic cancer	4.05e-05	0.000206	CcSEcCtD
Amiloride—Nausea—Alitretinoin—hematologic cancer	4.03e-05	0.000205	CcSEcCtD
Amiloride—Visual impairment—Epirubicin—hematologic cancer	4.03e-05	0.000205	CcSEcCtD
Amiloride—Rash—Irinotecan—hematologic cancer	4.02e-05	0.000204	CcSEcCtD
Amiloride—Rash—Mitoxantrone—hematologic cancer	4.02e-05	0.000204	CcSEcCtD
Amiloride—Dermatitis—Irinotecan—hematologic cancer	4.01e-05	0.000204	CcSEcCtD
Amiloride—Dermatitis—Mitoxantrone—hematologic cancer	4.01e-05	0.000204	CcSEcCtD
Amiloride—Headache—Mitoxantrone—hematologic cancer	3.99e-05	0.000203	CcSEcCtD
Amiloride—Headache—Irinotecan—hematologic cancer	3.99e-05	0.000203	CcSEcCtD
Amiloride—Nausea—Ifosfamide—hematologic cancer	3.99e-05	0.000202	CcSEcCtD
Amiloride—Musculoskeletal discomfort—Dexamethasone—hematologic cancer	3.97e-05	0.000202	CcSEcCtD
Amiloride—Musculoskeletal discomfort—Betamethasone—hematologic cancer	3.97e-05	0.000202	CcSEcCtD
Amiloride—Arthralgia—Prednisone—hematologic cancer	3.96e-05	0.000201	CcSEcCtD
Amiloride—Feeling abnormal—Triamcinolone—hematologic cancer	3.96e-05	0.000201	CcSEcCtD
Amiloride—Diarrhoea—Cisplatin—hematologic cancer	3.96e-05	0.000201	CcSEcCtD
Amiloride—Alopecia—Methotrexate—hematologic cancer	3.95e-05	0.000201	CcSEcCtD
Amiloride—Vomiting—Gemcitabine—hematologic cancer	3.95e-05	0.0002	CcSEcCtD
Amiloride—Insomnia—Dexamethasone—hematologic cancer	3.95e-05	0.0002	CcSEcCtD
Amiloride—Insomnia—Betamethasone—hematologic cancer	3.95e-05	0.0002	CcSEcCtD
Amiloride—Bradycardia—Doxorubicin—hematologic cancer	3.94e-05	0.0002	CcSEcCtD
Amiloride—Paraesthesia—Dexamethasone—hematologic cancer	3.92e-05	0.000199	CcSEcCtD
Amiloride—Paraesthesia—Betamethasone—hematologic cancer	3.92e-05	0.000199	CcSEcCtD
Amiloride—Rash—Gemcitabine—hematologic cancer	3.91e-05	0.000199	CcSEcCtD
Amiloride—Dermatitis—Gemcitabine—hematologic cancer	3.91e-05	0.000199	CcSEcCtD
Amiloride—Tinnitus—Epirubicin—hematologic cancer	3.9e-05	0.000198	CcSEcCtD
Amiloride—Haemoglobin—Doxorubicin—hematologic cancer	3.89e-05	0.000198	CcSEcCtD
Amiloride—Headache—Gemcitabine—hematologic cancer	3.89e-05	0.000198	CcSEcCtD
Amiloride—Nausea—Vincristine—hematologic cancer	3.89e-05	0.000197	CcSEcCtD
Amiloride—Haemorrhage—Doxorubicin—hematologic cancer	3.87e-05	0.000197	CcSEcCtD
Amiloride—Dyspepsia—Dexamethasone—hematologic cancer	3.84e-05	0.000195	CcSEcCtD
Amiloride—Dyspepsia—Betamethasone—hematologic cancer	3.84e-05	0.000195	CcSEcCtD
Amiloride—Asthenia—Etoposide—hematologic cancer	3.8e-05	0.000193	CcSEcCtD
Amiloride—Decreased appetite—Dexamethasone—hematologic cancer	3.79e-05	0.000193	CcSEcCtD
Amiloride—Decreased appetite—Betamethasone—hematologic cancer	3.79e-05	0.000193	CcSEcCtD
Amiloride—Nausea—Mitoxantrone—hematologic cancer	3.79e-05	0.000192	CcSEcCtD
Amiloride—Nausea—Irinotecan—hematologic cancer	3.79e-05	0.000192	CcSEcCtD
Amiloride—Gastrointestinal disorder—Dexamethasone—hematologic cancer	3.77e-05	0.000191	CcSEcCtD
Amiloride—Gastrointestinal disorder—Betamethasone—hematologic cancer	3.77e-05	0.000191	CcSEcCtD
Amiloride—Back pain—Methotrexate—hematologic cancer	3.76e-05	0.000191	CcSEcCtD
Amiloride—Fatigue—Betamethasone—hematologic cancer	3.76e-05	0.000191	CcSEcCtD
Amiloride—Fatigue—Dexamethasone—hematologic cancer	3.76e-05	0.000191	CcSEcCtD
Amiloride—Pruritus—Etoposide—hematologic cancer	3.75e-05	0.00019	CcSEcCtD
Amiloride—Shock—Prednisone—hematologic cancer	3.74e-05	0.00019	CcSEcCtD
Amiloride—Pain—Betamethasone—hematologic cancer	3.73e-05	0.000189	CcSEcCtD
Amiloride—Pain—Dexamethasone—hematologic cancer	3.73e-05	0.000189	CcSEcCtD
Amiloride—Visual impairment—Doxorubicin—hematologic cancer	3.73e-05	0.000189	CcSEcCtD
Amiloride—Alopecia—Epirubicin—hematologic cancer	3.7e-05	0.000188	CcSEcCtD
Amiloride—Nausea—Gemcitabine—hematologic cancer	3.69e-05	0.000187	CcSEcCtD
Amiloride—Vomiting—Cisplatin—hematologic cancer	3.68e-05	0.000187	CcSEcCtD
Amiloride—Rash—Cisplatin—hematologic cancer	3.65e-05	0.000185	CcSEcCtD
Amiloride—Dermatitis—Cisplatin—hematologic cancer	3.64e-05	0.000185	CcSEcCtD
Amiloride—Diarrhoea—Etoposide—hematologic cancer	3.63e-05	0.000184	CcSEcCtD
Amiloride—Anorexia—Prednisone—hematologic cancer	3.62e-05	0.000184	CcSEcCtD
Amiloride—Tinnitus—Doxorubicin—hematologic cancer	3.61e-05	0.000183	CcSEcCtD
Amiloride—Feeling abnormal—Dexamethasone—hematologic cancer	3.59e-05	0.000183	CcSEcCtD
Amiloride—Feeling abnormal—Betamethasone—hematologic cancer	3.59e-05	0.000183	CcSEcCtD
Amiloride—Flatulence—Epirubicin—hematologic cancer	3.59e-05	0.000182	CcSEcCtD
Amiloride—Tension—Epirubicin—hematologic cancer	3.57e-05	0.000181	CcSEcCtD
Amiloride—Gastrointestinal pain—Betamethasone—hematologic cancer	3.57e-05	0.000181	CcSEcCtD
Amiloride—Gastrointestinal pain—Dexamethasone—hematologic cancer	3.57e-05	0.000181	CcSEcCtD
Amiloride—Nervousness—Epirubicin—hematologic cancer	3.54e-05	0.00018	CcSEcCtD
Amiloride—Back pain—Epirubicin—hematologic cancer	3.52e-05	0.000179	CcSEcCtD
Amiloride—Dizziness—Etoposide—hematologic cancer	3.51e-05	0.000178	CcSEcCtD
Amiloride—Muscle spasms—Epirubicin—hematologic cancer	3.5e-05	0.000178	CcSEcCtD
Amiloride—Vertigo—Methotrexate—hematologic cancer	3.5e-05	0.000178	CcSEcCtD
Amiloride—Musculoskeletal discomfort—Prednisone—hematologic cancer	3.46e-05	0.000176	CcSEcCtD
Amiloride—Dizziness—Prednisolone—hematologic cancer	3.46e-05	0.000176	CcSEcCtD
Amiloride—Asthenia—Triamcinolone—hematologic cancer	3.45e-05	0.000175	CcSEcCtD
Amiloride—Abdominal pain—Dexamethasone—hematologic cancer	3.45e-05	0.000175	CcSEcCtD
Amiloride—Abdominal pain—Betamethasone—hematologic cancer	3.45e-05	0.000175	CcSEcCtD
Amiloride—Nausea—Cisplatin—hematologic cancer	3.44e-05	0.000175	CcSEcCtD
Amiloride—Insomnia—Prednisone—hematologic cancer	3.44e-05	0.000175	CcSEcCtD
Amiloride—Alopecia—Doxorubicin—hematologic cancer	3.42e-05	0.000174	CcSEcCtD
Amiloride—Paraesthesia—Prednisone—hematologic cancer	3.41e-05	0.000173	CcSEcCtD
Amiloride—Pruritus—Triamcinolone—hematologic cancer	3.4e-05	0.000173	CcSEcCtD
Amiloride—Cough—Methotrexate—hematologic cancer	3.39e-05	0.000172	CcSEcCtD
Amiloride—Vomiting—Etoposide—hematologic cancer	3.37e-05	0.000171	CcSEcCtD
Amiloride—Dyspepsia—Prednisone—hematologic cancer	3.34e-05	0.00017	CcSEcCtD
Amiloride—Rash—Etoposide—hematologic cancer	3.34e-05	0.00017	CcSEcCtD
Amiloride—Dermatitis—Etoposide—hematologic cancer	3.34e-05	0.00017	CcSEcCtD
Amiloride—Headache—Etoposide—hematologic cancer	3.32e-05	0.000169	CcSEcCtD
Amiloride—Flatulence—Doxorubicin—hematologic cancer	3.32e-05	0.000169	CcSEcCtD
Amiloride—Chest pain—Methotrexate—hematologic cancer	3.31e-05	0.000168	CcSEcCtD
Amiloride—Arthralgia—Methotrexate—hematologic cancer	3.31e-05	0.000168	CcSEcCtD
Amiloride—Tension—Doxorubicin—hematologic cancer	3.31e-05	0.000168	CcSEcCtD
Amiloride—Decreased appetite—Prednisone—hematologic cancer	3.3e-05	0.000168	CcSEcCtD
Amiloride—Rash—Prednisolone—hematologic cancer	3.3e-05	0.000167	CcSEcCtD
Amiloride—Dermatitis—Prednisolone—hematologic cancer	3.29e-05	0.000167	CcSEcCtD
Amiloride—Fatigue—Prednisone—hematologic cancer	3.28e-05	0.000166	CcSEcCtD
Amiloride—Headache—Prednisolone—hematologic cancer	3.28e-05	0.000166	CcSEcCtD
Amiloride—Nervousness—Doxorubicin—hematologic cancer	3.27e-05	0.000166	CcSEcCtD
Amiloride—Vertigo—Epirubicin—hematologic cancer	3.27e-05	0.000166	CcSEcCtD
Amiloride—Back pain—Doxorubicin—hematologic cancer	3.26e-05	0.000166	CcSEcCtD
Amiloride—Constipation—Prednisone—hematologic cancer	3.25e-05	0.000165	CcSEcCtD
Amiloride—Muscle spasms—Doxorubicin—hematologic cancer	3.24e-05	0.000165	CcSEcCtD
Amiloride—Palpitations—Epirubicin—hematologic cancer	3.22e-05	0.000163	CcSEcCtD
Amiloride—Confusional state—Methotrexate—hematologic cancer	3.2e-05	0.000163	CcSEcCtD
Amiloride—Dizziness—Triamcinolone—hematologic cancer	3.18e-05	0.000161	CcSEcCtD
Amiloride—Cough—Epirubicin—hematologic cancer	3.18e-05	0.000161	CcSEcCtD
Amiloride—Nausea—Etoposide—hematologic cancer	3.15e-05	0.00016	CcSEcCtD
Amiloride—Feeling abnormal—Prednisone—hematologic cancer	3.13e-05	0.000159	CcSEcCtD
Amiloride—Asthenia—Betamethasone—hematologic cancer	3.13e-05	0.000159	CcSEcCtD
Amiloride—Asthenia—Dexamethasone—hematologic cancer	3.13e-05	0.000159	CcSEcCtD
Amiloride—Gastrointestinal pain—Prednisone—hematologic cancer	3.11e-05	0.000158	CcSEcCtD
Amiloride—Nausea—Prednisolone—hematologic cancer	3.11e-05	0.000158	CcSEcCtD
Amiloride—Arthralgia—Epirubicin—hematologic cancer	3.1e-05	0.000157	CcSEcCtD
Amiloride—Chest pain—Epirubicin—hematologic cancer	3.1e-05	0.000157	CcSEcCtD
Amiloride—Pruritus—Betamethasone—hematologic cancer	3.09e-05	0.000157	CcSEcCtD
Amiloride—Pruritus—Dexamethasone—hematologic cancer	3.09e-05	0.000157	CcSEcCtD
Amiloride—Vomiting—Triamcinolone—hematologic cancer	3.06e-05	0.000155	CcSEcCtD
Amiloride—Rash—Triamcinolone—hematologic cancer	3.03e-05	0.000154	CcSEcCtD
Amiloride—Dermatitis—Triamcinolone—hematologic cancer	3.03e-05	0.000154	CcSEcCtD
Amiloride—Vertigo—Doxorubicin—hematologic cancer	3.03e-05	0.000154	CcSEcCtD
Amiloride—Anorexia—Methotrexate—hematologic cancer	3.03e-05	0.000154	CcSEcCtD
Amiloride—Headache—Triamcinolone—hematologic cancer	3.01e-05	0.000153	CcSEcCtD
Amiloride—Abdominal pain—Prednisone—hematologic cancer	3e-05	0.000153	CcSEcCtD
Amiloride—Confusional state—Epirubicin—hematologic cancer	3e-05	0.000152	CcSEcCtD
Amiloride—Diarrhoea—Betamethasone—hematologic cancer	2.98e-05	0.000152	CcSEcCtD
Amiloride—Diarrhoea—Dexamethasone—hematologic cancer	2.98e-05	0.000152	CcSEcCtD
Amiloride—Palpitations—Doxorubicin—hematologic cancer	2.98e-05	0.000151	CcSEcCtD
Amiloride—Cough—Doxorubicin—hematologic cancer	2.94e-05	0.000149	CcSEcCtD
Amiloride—Shock—Epirubicin—hematologic cancer	2.92e-05	0.000148	CcSEcCtD
Amiloride—Musculoskeletal discomfort—Methotrexate—hematologic cancer	2.89e-05	0.000147	CcSEcCtD
Amiloride—Dizziness—Dexamethasone—hematologic cancer	2.88e-05	0.000147	CcSEcCtD
Amiloride—Dizziness—Betamethasone—hematologic cancer	2.88e-05	0.000147	CcSEcCtD
Amiloride—Insomnia—Methotrexate—hematologic cancer	2.87e-05	0.000146	CcSEcCtD
Amiloride—Arthralgia—Doxorubicin—hematologic cancer	2.87e-05	0.000146	CcSEcCtD
Amiloride—Chest pain—Doxorubicin—hematologic cancer	2.87e-05	0.000146	CcSEcCtD
Amiloride—Nausea—Triamcinolone—hematologic cancer	2.86e-05	0.000145	CcSEcCtD
Amiloride—Paraesthesia—Methotrexate—hematologic cancer	2.85e-05	0.000145	CcSEcCtD
Amiloride—Anorexia—Epirubicin—hematologic cancer	2.83e-05	0.000144	CcSEcCtD
Amiloride—Dyspnoea—Methotrexate—hematologic cancer	2.83e-05	0.000144	CcSEcCtD
Amiloride—Somnolence—Methotrexate—hematologic cancer	2.82e-05	0.000143	CcSEcCtD
Amiloride—Dyspepsia—Methotrexate—hematologic cancer	2.79e-05	0.000142	CcSEcCtD
Amiloride—Vomiting—Dexamethasone—hematologic cancer	2.77e-05	0.000141	CcSEcCtD
Amiloride—Vomiting—Betamethasone—hematologic cancer	2.77e-05	0.000141	CcSEcCtD
Amiloride—Confusional state—Doxorubicin—hematologic cancer	2.77e-05	0.000141	CcSEcCtD
Amiloride—Decreased appetite—Methotrexate—hematologic cancer	2.76e-05	0.00014	CcSEcCtD
Amiloride—Rash—Dexamethasone—hematologic cancer	2.75e-05	0.00014	CcSEcCtD
Amiloride—Rash—Betamethasone—hematologic cancer	2.75e-05	0.00014	CcSEcCtD
Amiloride—Dermatitis—Dexamethasone—hematologic cancer	2.75e-05	0.00014	CcSEcCtD
Amiloride—Dermatitis—Betamethasone—hematologic cancer	2.75e-05	0.00014	CcSEcCtD
Amiloride—Gastrointestinal disorder—Methotrexate—hematologic cancer	2.74e-05	0.000139	CcSEcCtD
Amiloride—Fatigue—Methotrexate—hematologic cancer	2.74e-05	0.000139	CcSEcCtD
Amiloride—Headache—Betamethasone—hematologic cancer	2.73e-05	0.000139	CcSEcCtD
Amiloride—Headache—Dexamethasone—hematologic cancer	2.73e-05	0.000139	CcSEcCtD
Amiloride—Asthenia—Prednisone—hematologic cancer	2.73e-05	0.000138	CcSEcCtD
Amiloride—Pain—Methotrexate—hematologic cancer	2.72e-05	0.000138	CcSEcCtD
Amiloride—Musculoskeletal discomfort—Epirubicin—hematologic cancer	2.71e-05	0.000138	CcSEcCtD
Amiloride—Shock—Doxorubicin—hematologic cancer	2.7e-05	0.000137	CcSEcCtD
Amiloride—Pruritus—Prednisone—hematologic cancer	2.69e-05	0.000137	CcSEcCtD
Amiloride—Insomnia—Epirubicin—hematologic cancer	2.69e-05	0.000137	CcSEcCtD
Amiloride—Paraesthesia—Epirubicin—hematologic cancer	2.67e-05	0.000136	CcSEcCtD
Amiloride—Dyspnoea—Epirubicin—hematologic cancer	2.65e-05	0.000135	CcSEcCtD
Amiloride—Somnolence—Epirubicin—hematologic cancer	2.64e-05	0.000134	CcSEcCtD
Amiloride—Anorexia—Doxorubicin—hematologic cancer	2.62e-05	0.000133	CcSEcCtD
Amiloride—Feeling abnormal—Methotrexate—hematologic cancer	2.62e-05	0.000133	CcSEcCtD
Amiloride—Dyspepsia—Epirubicin—hematologic cancer	2.62e-05	0.000133	CcSEcCtD
Amiloride—Diarrhoea—Prednisone—hematologic cancer	2.6e-05	0.000132	CcSEcCtD
Amiloride—Gastrointestinal pain—Methotrexate—hematologic cancer	2.6e-05	0.000132	CcSEcCtD
Amiloride—Nausea—Dexamethasone—hematologic cancer	2.59e-05	0.000132	CcSEcCtD
Amiloride—Nausea—Betamethasone—hematologic cancer	2.59e-05	0.000132	CcSEcCtD
Amiloride—Decreased appetite—Epirubicin—hematologic cancer	2.58e-05	0.000131	CcSEcCtD
Amiloride—Gastrointestinal disorder—Epirubicin—hematologic cancer	2.57e-05	0.00013	CcSEcCtD
Amiloride—Fatigue—Epirubicin—hematologic cancer	2.56e-05	0.00013	CcSEcCtD
Amiloride—Pain—Epirubicin—hematologic cancer	2.54e-05	0.000129	CcSEcCtD
Amiloride—Constipation—Epirubicin—hematologic cancer	2.54e-05	0.000129	CcSEcCtD
Amiloride—Dizziness—Prednisone—hematologic cancer	2.51e-05	0.000128	CcSEcCtD
Amiloride—Abdominal pain—Methotrexate—hematologic cancer	2.51e-05	0.000127	CcSEcCtD
Amiloride—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	2.5e-05	0.000127	CcSEcCtD
Amiloride—Insomnia—Doxorubicin—hematologic cancer	2.49e-05	0.000126	CcSEcCtD
Amiloride—Paraesthesia—Doxorubicin—hematologic cancer	2.47e-05	0.000125	CcSEcCtD
Amiloride—Dyspnoea—Doxorubicin—hematologic cancer	2.45e-05	0.000124	CcSEcCtD
Amiloride—Feeling abnormal—Epirubicin—hematologic cancer	2.45e-05	0.000124	CcSEcCtD
Amiloride—Somnolence—Doxorubicin—hematologic cancer	2.44e-05	0.000124	CcSEcCtD
Amiloride—Gastrointestinal pain—Epirubicin—hematologic cancer	2.43e-05	0.000123	CcSEcCtD
Amiloride—Dyspepsia—Doxorubicin—hematologic cancer	2.42e-05	0.000123	CcSEcCtD
Amiloride—Vomiting—Prednisone—hematologic cancer	2.42e-05	0.000123	CcSEcCtD
Amiloride—Rash—Prednisone—hematologic cancer	2.4e-05	0.000122	CcSEcCtD
Amiloride—Dermatitis—Prednisone—hematologic cancer	2.39e-05	0.000122	CcSEcCtD
Amiloride—Decreased appetite—Doxorubicin—hematologic cancer	2.39e-05	0.000121	CcSEcCtD
Amiloride—Headache—Prednisone—hematologic cancer	2.38e-05	0.000121	CcSEcCtD
Amiloride—Gastrointestinal disorder—Doxorubicin—hematologic cancer	2.37e-05	0.000121	CcSEcCtD
Amiloride—Fatigue—Doxorubicin—hematologic cancer	2.37e-05	0.00012	CcSEcCtD
Amiloride—Constipation—Doxorubicin—hematologic cancer	2.35e-05	0.000119	CcSEcCtD
Amiloride—Pain—Doxorubicin—hematologic cancer	2.35e-05	0.000119	CcSEcCtD
Amiloride—Abdominal pain—Epirubicin—hematologic cancer	2.35e-05	0.000119	CcSEcCtD
Amiloride—Asthenia—Methotrexate—hematologic cancer	2.28e-05	0.000116	CcSEcCtD
Amiloride—Feeling abnormal—Doxorubicin—hematologic cancer	2.27e-05	0.000115	CcSEcCtD
Amiloride—Nausea—Prednisone—hematologic cancer	2.26e-05	0.000115	CcSEcCtD
Amiloride—Gastrointestinal pain—Doxorubicin—hematologic cancer	2.25e-05	0.000114	CcSEcCtD
Amiloride—Pruritus—Methotrexate—hematologic cancer	2.25e-05	0.000114	CcSEcCtD
Amiloride—Abdominal pain—Doxorubicin—hematologic cancer	2.17e-05	0.00011	CcSEcCtD
Amiloride—Diarrhoea—Methotrexate—hematologic cancer	2.17e-05	0.00011	CcSEcCtD
Amiloride—SLC22A4—SLC-mediated transmembrane transport—ALB—hematologic cancer	2.16e-05	0.000149	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—CYCS—hematologic cancer	2.16e-05	0.000148	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—HSP90AA1—hematologic cancer	2.14e-05	0.000147	CbGpPWpGaD
Amiloride—Asthenia—Epirubicin—hematologic cancer	2.13e-05	0.000108	CcSEcCtD
Amiloride—SLC9A1—Disease—CD86—hematologic cancer	2.13e-05	0.000146	CbGpPWpGaD
Amiloride—SLC22A1—Neuronal System—CAMK2D—hematologic cancer	2.11e-05	0.000145	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—SLC26A4—hematologic cancer	2.11e-05	0.000145	CbGpPWpGaD
Amiloride—SLC22A4—Transmembrane transport of small molecules—CYCS—hematologic cancer	2.11e-05	0.000145	CbGpPWpGaD
Amiloride—Pruritus—Epirubicin—hematologic cancer	2.1e-05	0.000107	CcSEcCtD
Amiloride—Dizziness—Methotrexate—hematologic cancer	2.1e-05	0.000107	CcSEcCtD
Amiloride—SLC9A1—Disease—HES1—hematologic cancer	2.1e-05	0.000144	CbGpPWpGaD
Amiloride—SLC9A1—Disease—NCOR1—hematologic cancer	2.09e-05	0.000143	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—ATP4A—hematologic cancer	2.07e-05	0.000142	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—SGK1—hematologic cancer	2.07e-05	0.000142	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—ANXA2—hematologic cancer	2.07e-05	0.000142	CbGpPWpGaD
Amiloride—SLC9A1—Disease—FGF1—hematologic cancer	2.06e-05	0.000142	CbGpPWpGaD
Amiloride—SLC9A1—Disease—FOXO1—hematologic cancer	2.03e-05	0.00014	CbGpPWpGaD
Amiloride—Diarrhoea—Epirubicin—hematologic cancer	2.03e-05	0.000103	CcSEcCtD
Amiloride—PLAU—Hemostasis—IL2—hematologic cancer	2.03e-05	0.00014	CbGpPWpGaD
Amiloride—SLC9A1—Disease—PDGFRB—hematologic cancer	2.03e-05	0.000139	CbGpPWpGaD
Amiloride—Vomiting—Methotrexate—hematologic cancer	2.02e-05	0.000103	CcSEcCtD
Amiloride—Rash—Methotrexate—hematologic cancer	2e-05	0.000102	CcSEcCtD
Amiloride—Dermatitis—Methotrexate—hematologic cancer	2e-05	0.000102	CcSEcCtD
Amiloride—SLC9A1—Disease—PDGFRA—hematologic cancer	2e-05	0.000137	CbGpPWpGaD
Amiloride—SLC9A1—Disease—PRKCG—hematologic cancer	1.99e-05	0.000137	CbGpPWpGaD
Amiloride—SLC9A1—Disease—JAK1—hematologic cancer	1.99e-05	0.000137	CbGpPWpGaD
Amiloride—Headache—Methotrexate—hematologic cancer	1.99e-05	0.000101	CcSEcCtD
Amiloride—Asthenia—Doxorubicin—hematologic cancer	1.97e-05	0.0001	CcSEcCtD
Amiloride—Dizziness—Epirubicin—hematologic cancer	1.96e-05	9.98e-05	CcSEcCtD
Amiloride—Pruritus—Doxorubicin—hematologic cancer	1.95e-05	9.88e-05	CcSEcCtD
Amiloride—SLC22A1—Transmembrane transport of small molecules—ANXA2—hematologic cancer	1.93e-05	0.000132	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—ATP4A—hematologic cancer	1.93e-05	0.000132	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—SGK1—hematologic cancer	1.93e-05	0.000132	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—GSTP1—hematologic cancer	1.9e-05	0.000131	CbGpPWpGaD
Amiloride—Vomiting—Epirubicin—hematologic cancer	1.89e-05	9.6e-05	CcSEcCtD
Amiloride—Nausea—Methotrexate—hematologic cancer	1.89e-05	9.58e-05	CcSEcCtD
Amiloride—Diarrhoea—Doxorubicin—hematologic cancer	1.88e-05	9.55e-05	CcSEcCtD
Amiloride—Rash—Epirubicin—hematologic cancer	1.87e-05	9.52e-05	CcSEcCtD
Amiloride—Dermatitis—Epirubicin—hematologic cancer	1.87e-05	9.51e-05	CcSEcCtD
Amiloride—SLC22A2—Transmission across Chemical Synapses—PRKCG—hematologic cancer	1.87e-05	0.000129	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—TUBB2A—hematologic cancer	1.86e-05	0.000128	CbGpPWpGaD
Amiloride—Headache—Epirubicin—hematologic cancer	1.86e-05	9.45e-05	CcSEcCtD
Amiloride—SLC22A2—Metabolism—PHYH—hematologic cancer	1.84e-05	0.000127	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—GMPS—hematologic cancer	1.84e-05	0.000127	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—FTCD—hematologic cancer	1.84e-05	0.000127	CbGpPWpGaD
Amiloride—SLC9A1—Disease—MTHFR—hematologic cancer	1.84e-05	0.000127	CbGpPWpGaD
Amiloride—SLC9A1—Disease—TERT—hematologic cancer	1.84e-05	0.000126	CbGpPWpGaD
Amiloride—SLC9A1—Disease—HLA-A—hematologic cancer	1.84e-05	0.000126	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—EP300—hematologic cancer	1.82e-05	0.000125	CbGpPWpGaD
Amiloride—Dizziness—Doxorubicin—hematologic cancer	1.82e-05	9.23e-05	CcSEcCtD
Amiloride—SLC9A1—Metabolism—ABCB1—hematologic cancer	1.8e-05	0.000124	CbGpPWpGaD
Amiloride—SLC9A1—Disease—PDGFB—hematologic cancer	1.79e-05	0.000123	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—SRC—hematologic cancer	1.77e-05	0.000122	CbGpPWpGaD
Amiloride—Nausea—Epirubicin—hematologic cancer	1.76e-05	8.96e-05	CcSEcCtD
Amiloride—SLC22A4—Transmembrane transport of small molecules—ABCB1—hematologic cancer	1.76e-05	0.000121	CbGpPWpGaD
Amiloride—SLC9A1—Disease—TSC2—hematologic cancer	1.75e-05	0.000121	CbGpPWpGaD
Amiloride—Vomiting—Doxorubicin—hematologic cancer	1.75e-05	8.88e-05	CcSEcCtD
Amiloride—SLC9A1—Metabolism—GSTM1—hematologic cancer	1.75e-05	0.00012	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—NCOR1—hematologic cancer	1.75e-05	0.00012	CbGpPWpGaD
Amiloride—SLC22A1—Transmission across Chemical Synapses—PRKCG—hematologic cancer	1.74e-05	0.00012	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—TUBB2A—hematologic cancer	1.74e-05	0.000119	CbGpPWpGaD
Amiloride—Rash—Doxorubicin—hematologic cancer	1.73e-05	8.8e-05	CcSEcCtD
Amiloride—Dermatitis—Doxorubicin—hematologic cancer	1.73e-05	8.8e-05	CcSEcCtD
Amiloride—PLAU—Hemostasis—VEGFA—hematologic cancer	1.73e-05	0.000119	CbGpPWpGaD
Amiloride—Headache—Doxorubicin—hematologic cancer	1.72e-05	8.75e-05	CcSEcCtD
Amiloride—SLC22A1—Metabolism—GMPS—hematologic cancer	1.72e-05	0.000118	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—FTCD—hematologic cancer	1.72e-05	0.000118	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—PHYH—hematologic cancer	1.72e-05	0.000118	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—NRAS—hematologic cancer	1.71e-05	0.000117	CbGpPWpGaD
Amiloride—SLC9A1—Disease—FGFR3—hematologic cancer	1.69e-05	0.000116	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—SMPD3—hematologic cancer	1.69e-05	0.000116	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—ABCC3—hematologic cancer	1.63e-05	0.000112	CbGpPWpGaD
Amiloride—Nausea—Doxorubicin—hematologic cancer	1.63e-05	8.29e-05	CcSEcCtD
Amiloride—PLAU—Hemostasis—MAPK3—hematologic cancer	1.63e-05	0.000112	CbGpPWpGaD
Amiloride—SLC9A1—Disease—BAD—hematologic cancer	1.6e-05	0.00011	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—TGFB1—hematologic cancer	1.58e-05	0.000109	CbGpPWpGaD
Amiloride—SLC9A1—Disease—NOTCH1—hematologic cancer	1.58e-05	0.000109	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—SMPD3—hematologic cancer	1.57e-05	0.000108	CbGpPWpGaD
Amiloride—SLC9A1—Disease—CD80—hematologic cancer	1.55e-05	0.000107	CbGpPWpGaD
Amiloride—SLC9A1—Disease—KIT—hematologic cancer	1.55e-05	0.000106	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—MTHFR—hematologic cancer	1.54e-05	0.000106	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—ABCC3—hematologic cancer	1.52e-05	0.000105	CbGpPWpGaD
Amiloride—SLC9A1—Disease—PTPN11—hematologic cancer	1.52e-05	0.000105	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—SLC22A1—hematologic cancer	1.5e-05	0.000103	CbGpPWpGaD
Amiloride—SLC9A1—Disease—CREB1—hematologic cancer	1.47e-05	0.000101	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—B3GAT1—hematologic cancer	1.47e-05	0.000101	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—DCK—hematologic cancer	1.47e-05	0.000101	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—ASNS—hematologic cancer	1.47e-05	0.000101	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—KRAS—hematologic cancer	1.47e-05	0.000101	CbGpPWpGaD
Amiloride—SLC9A1—Disease—BRAF—hematologic cancer	1.46e-05	0.0001	CbGpPWpGaD
Amiloride—SLC9A1—Disease—IL6R—hematologic cancer	1.44e-05	9.88e-05	CbGpPWpGaD
Amiloride—SLC9A1—Disease—CREBBP—hematologic cancer	1.44e-05	9.87e-05	CbGpPWpGaD
Amiloride—SLC22A2—Neuronal System—PRKCG—hematologic cancer	1.43e-05	9.85e-05	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—NUP98—hematologic cancer	1.41e-05	9.7e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—HDC—hematologic cancer	1.4e-05	9.6e-05	CbGpPWpGaD
Amiloride—SLC22A2—Transmission across Chemical Synapses—CREB1—hematologic cancer	1.39e-05	9.52e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—ASNS—hematologic cancer	1.37e-05	9.44e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—B3GAT1—hematologic cancer	1.37e-05	9.44e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—DCK—hematologic cancer	1.37e-05	9.44e-05	CbGpPWpGaD
Amiloride—SLC9A1—Disease—MAP2K1—hematologic cancer	1.37e-05	9.42e-05	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—ADCY7—hematologic cancer	1.37e-05	9.41e-05	CbGpPWpGaD
Amiloride—SLC22A2—Transmission across Chemical Synapses—BRAF—hematologic cancer	1.37e-05	9.4e-05	CbGpPWpGaD
Amiloride—SLC9A1—Disease—PIK3CD—hematologic cancer	1.36e-05	9.36e-05	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—NUP214—hematologic cancer	1.36e-05	9.35e-05	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—PIK3CA—hematologic cancer	1.35e-05	9.26e-05	CbGpPWpGaD
Amiloride—SLC22A1—Neuronal System—PRKCG—hematologic cancer	1.34e-05	9.18e-05	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—ABCG2—hematologic cancer	1.33e-05	9.16e-05	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—NUP98—hematologic cancer	1.32e-05	9.04e-05	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—TP53—hematologic cancer	1.3e-05	8.96e-05	CbGpPWpGaD
Amiloride—SLC9A1—Disease—FGF2—hematologic cancer	1.3e-05	8.96e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—HDC—hematologic cancer	1.3e-05	8.95e-05	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—PIK3CG—hematologic cancer	1.3e-05	8.92e-05	CbGpPWpGaD
Amiloride—SLC22A1—Transmission across Chemical Synapses—CREB1—hematologic cancer	1.29e-05	8.87e-05	CbGpPWpGaD
Amiloride—SLC9A1—Disease—PIK3R1—hematologic cancer	1.29e-05	8.84e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—CDA—hematologic cancer	1.28e-05	8.78e-05	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—ADCY7—hematologic cancer	1.28e-05	8.77e-05	CbGpPWpGaD
Amiloride—SLC22A1—Transmission across Chemical Synapses—BRAF—hematologic cancer	1.28e-05	8.76e-05	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—NUP214—hematologic cancer	1.27e-05	8.71e-05	CbGpPWpGaD
Amiloride—SLC9A1—Disease—JAK2—hematologic cancer	1.25e-05	8.59e-05	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—HRAS—hematologic cancer	1.25e-05	8.57e-05	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—ABCG2—hematologic cancer	1.24e-05	8.54e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—PC—hematologic cancer	1.23e-05	8.45e-05	CbGpPWpGaD
Amiloride—SLC9A1—Disease—MDM2—hematologic cancer	1.22e-05	8.38e-05	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—CREBBP—hematologic cancer	1.2e-05	8.27e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—CDA—hematologic cancer	1.19e-05	8.19e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—SLC35B2—hematologic cancer	1.19e-05	8.17e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—GBA—hematologic cancer	1.19e-05	8.17e-05	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—TFRC—hematologic cancer	1.19e-05	8.16e-05	CbGpPWpGaD
Amiloride—SLC9A1—Disease—MTOR—hematologic cancer	1.19e-05	8.16e-05	CbGpPWpGaD
Amiloride—SLC9A1—Disease—PIK3CB—hematologic cancer	1.19e-05	8.16e-05	CbGpPWpGaD
Amiloride—SLC9A1—Disease—CD4—hematologic cancer	1.18e-05	8.14e-05	CbGpPWpGaD
Amiloride—SLC22A4—Transmembrane transport of small molecules—CREBBP—hematologic cancer	1.18e-05	8.08e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—PC—hematologic cancer	1.15e-05	7.88e-05	CbGpPWpGaD
Amiloride—SLC22A2—Transmission across Chemical Synapses—MDM2—hematologic cancer	1.15e-05	7.88e-05	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—PIK3CD—hematologic cancer	1.14e-05	7.84e-05	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—ALB—hematologic cancer	1.13e-05	7.74e-05	CbGpPWpGaD
Amiloride—SLC9A1—Disease—CDKN1B—hematologic cancer	1.11e-05	7.66e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—SLC35B2—hematologic cancer	1.11e-05	7.61e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—GBA—hematologic cancer	1.11e-05	7.61e-05	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—TFRC—hematologic cancer	1.11e-05	7.61e-05	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—AKT1—hematologic cancer	1.1e-05	7.57e-05	CbGpPWpGaD
Amiloride—SLC22A4—Transmembrane transport of small molecules—ALB—hematologic cancer	1.1e-05	7.56e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—MTAP—hematologic cancer	1.09e-05	7.47e-05	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—PIK3R1—hematologic cancer	1.08e-05	7.4e-05	CbGpPWpGaD
Amiloride—SLC22A1—Transmission across Chemical Synapses—MDM2—hematologic cancer	1.07e-05	7.34e-05	CbGpPWpGaD
Amiloride—SLC22A2—Neuronal System—CREB1—hematologic cancer	1.06e-05	7.29e-05	CbGpPWpGaD
Amiloride—SLC22A2—Neuronal System—BRAF—hematologic cancer	1.05e-05	7.2e-05	CbGpPWpGaD
Amiloride—SLC9A1—Disease—CDKN1A—hematologic cancer	1.03e-05	7.06e-05	CbGpPWpGaD
Amiloride—SLC9A1—Disease—PTEN—hematologic cancer	1.03e-05	7.05e-05	CbGpPWpGaD
Amiloride—SLC22A2—SLC-mediated transmembrane transport—ALB—hematologic cancer	1.02e-05	7.04e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—MTAP—hematologic cancer	1.01e-05	6.96e-05	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—CYCS—hematologic cancer	9.97e-06	6.85e-05	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—PIK3CB—hematologic cancer	9.94e-06	6.83e-05	CbGpPWpGaD
Amiloride—SLC22A1—Neuronal System—CREB1—hematologic cancer	9.89e-06	6.8e-05	CbGpPWpGaD
Amiloride—SLC9A1—Disease—EP300—hematologic cancer	9.78e-06	6.72e-05	CbGpPWpGaD
Amiloride—SLC22A1—Neuronal System—BRAF—hematologic cancer	9.77e-06	6.71e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—FHL2—hematologic cancer	9.69e-06	6.66e-05	CbGpPWpGaD
Amiloride—SLC22A1—SLC-mediated transmembrane transport—ALB—hematologic cancer	9.54e-06	6.56e-05	CbGpPWpGaD
Amiloride—SLC9A1—Disease—SRC—hematologic cancer	9.51e-06	6.54e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—AGRN—hematologic cancer	9.5e-06	6.53e-05	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—CYCS—hematologic cancer	9.29e-06	6.38e-05	CbGpPWpGaD
Amiloride—SLC9A1—Disease—STAT3—hematologic cancer	9.17e-06	6.3e-05	CbGpPWpGaD
Amiloride—SLC9A1—Disease—NRAS—hematologic cancer	9.15e-06	6.29e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—FHL2—hematologic cancer	9.03e-06	6.2e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—HMMR—hematologic cancer	9.01e-06	6.19e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—IDH2—hematologic cancer	9.01e-06	6.19e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—AGRN—hematologic cancer	8.85e-06	6.08e-05	CbGpPWpGaD
Amiloride—SLC22A2—Neuronal System—MDM2—hematologic cancer	8.78e-06	6.03e-05	CbGpPWpGaD
Amiloride—SLC9A1—Disease—MAPK3—hematologic cancer	8.76e-06	6.02e-05	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—PTEN—hematologic cancer	8.59e-06	5.9e-05	CbGpPWpGaD
Amiloride—SLC9A1—Disease—MYC—hematologic cancer	8.52e-06	5.86e-05	CbGpPWpGaD
Amiloride—SLC9A1—Disease—TGFB1—hematologic cancer	8.5e-06	5.84e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—ARNTL—hematologic cancer	8.47e-06	5.82e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—IDH2—hematologic cancer	8.39e-06	5.77e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—HMMR—hematologic cancer	8.39e-06	5.77e-05	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—ABCB1—hematologic cancer	8.32e-06	5.72e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—CA9—hematologic cancer	8.24e-06	5.66e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—ACP5—hematologic cancer	8.24e-06	5.66e-05	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—EP300—hematologic cancer	8.19e-06	5.63e-05	CbGpPWpGaD
Amiloride—SLC22A1—Neuronal System—MDM2—hematologic cancer	8.19e-06	5.62e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—NCOR2—hematologic cancer	8.13e-06	5.59e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—ARNTL—hematologic cancer	7.89e-06	5.42e-05	CbGpPWpGaD
Amiloride—SLC9A1—Disease—KRAS—hematologic cancer	7.88e-06	5.41e-05	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—ABCB1—hematologic cancer	7.75e-06	5.33e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—IDH1—hematologic cancer	7.74e-06	5.32e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—ACP5—hematologic cancer	7.68e-06	5.28e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—CA9—hematologic cancer	7.68e-06	5.28e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—GSTO1—hematologic cancer	7.66e-06	5.26e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—TXN—hematologic cancer	7.66e-06	5.26e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—ABCC3—hematologic cancer	7.66e-06	5.26e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—NCOR2—hematologic cancer	7.58e-06	5.21e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—SPHK1—hematologic cancer	7.49e-06	5.15e-05	CbGpPWpGaD
Amiloride—SLC9A1—Disease—PIK3CA—hematologic cancer	7.24e-06	4.97e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—IDH1—hematologic cancer	7.22e-06	4.96e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—UGT1A1—hematologic cancer	7.2e-06	4.95e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—TXN—hematologic cancer	7.14e-06	4.9e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—ABCC3—hematologic cancer	7.14e-06	4.9e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—GSTO1—hematologic cancer	7.14e-06	4.9e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—SLC22A1—hematologic cancer	7e-06	4.81e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—CRABP1—hematologic cancer	7e-06	4.81e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—SPHK1—hematologic cancer	6.98e-06	4.8e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—ALOX5—hematologic cancer	6.82e-06	4.69e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—UGT1A1—hematologic cancer	6.71e-06	4.61e-05	CbGpPWpGaD
Amiloride—SLC9A1—Disease—HRAS—hematologic cancer	6.7e-06	4.6e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—NUP98—hematologic cancer	6.61e-06	4.54e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—CRABP1—hematologic cancer	6.53e-06	4.49e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—ADCY7—hematologic cancer	6.42e-06	4.41e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—NCOA3—hematologic cancer	6.42e-06	4.41e-05	CbGpPWpGaD
Amiloride—SLC9A1—Disease—IL6—hematologic cancer	6.41e-06	4.4e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—NUP214—hematologic cancer	6.37e-06	4.38e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—ALOX5—hematologic cancer	6.36e-06	4.37e-05	CbGpPWpGaD
Amiloride—SLC22A2—Transmission across Chemical Synapses—HRAS—hematologic cancer	6.29e-06	4.32e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—ABCG2—hematologic cancer	6.24e-06	4.29e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—MTR—hematologic cancer	6.24e-06	4.29e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—NUP98—hematologic cancer	6.16e-06	4.23e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—ENO2—hematologic cancer	6.12e-06	4.21e-05	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—PIK3CA—hematologic cancer	6.06e-06	4.16e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—ADCY7—hematologic cancer	5.98e-06	4.11e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—NCOA3—hematologic cancer	5.98e-06	4.11e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—NUP214—hematologic cancer	5.94e-06	4.08e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—GSTT1—hematologic cancer	5.94e-06	4.08e-05	CbGpPWpGaD
Amiloride—SLC9A1—Disease—AKT1—hematologic cancer	5.91e-06	4.06e-05	CbGpPWpGaD
Amiloride—SLC22A1—Transmission across Chemical Synapses—HRAS—hematologic cancer	5.86e-06	4.03e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—MTR—hematologic cancer	5.82e-06	4e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—ABCG2—hematologic cancer	5.82e-06	4e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—SDC1—hematologic cancer	5.8e-06	3.99e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—ENO2—hematologic cancer	5.71e-06	3.92e-05	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—CREBBP—hematologic cancer	5.56e-06	3.82e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—GSTT1—hematologic cancer	5.53e-06	3.8e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—SDC1—hematologic cancer	5.41e-06	3.72e-05	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—ALB—hematologic cancer	5.2e-06	3.58e-05	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—CREBBP—hematologic cancer	5.18e-06	3.56e-05	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—AKT1—hematologic cancer	4.95e-06	3.4e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—CD44—hematologic cancer	4.93e-06	3.39e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—NQO1—hematologic cancer	4.93e-06	3.39e-05	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—ALB—hematologic cancer	4.85e-06	3.33e-05	CbGpPWpGaD
Amiloride—SLC22A2—Neuronal System—HRAS—hematologic cancer	4.82e-06	3.31e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—CYCS—hematologic cancer	4.67e-06	3.21e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—HSP90AA1—hematologic cancer	4.64e-06	3.19e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—NQO1—hematologic cancer	4.6e-06	3.16e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—CD44—hematologic cancer	4.6e-06	3.16e-05	CbGpPWpGaD
Amiloride—SLC22A1—Neuronal System—HRAS—hematologic cancer	4.49e-06	3.09e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—CYCS—hematologic cancer	4.35e-06	2.99e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—HSP90AA1—hematologic cancer	4.32e-06	2.97e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—GSTP1—hematologic cancer	4.12e-06	2.83e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—ABCB1—hematologic cancer	3.9e-06	2.68e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—GSTP1—hematologic cancer	3.84e-06	2.64e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—NCOR1—hematologic cancer	3.78e-06	2.6e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—GSTM1—hematologic cancer	3.78e-06	2.6e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—ABCB1—hematologic cancer	3.63e-06	2.5e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—GSTM1—hematologic cancer	3.52e-06	2.42e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—NCOR1—hematologic cancer	3.52e-06	2.42e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—MTHFR—hematologic cancer	3.34e-06	2.3e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—MTHFR—hematologic cancer	3.12e-06	2.14e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—PIK3CG—hematologic cancer	2.81e-06	1.93e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—PIK3CG—hematologic cancer	2.62e-06	1.8e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—CREBBP—hematologic cancer	2.6e-06	1.79e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—PIK3CD—hematologic cancer	2.47e-06	1.7e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—ALB—hematologic cancer	2.44e-06	1.67e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—CREBBP—hematologic cancer	2.43e-06	1.67e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—PIK3R1—hematologic cancer	2.33e-06	1.6e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—PIK3CD—hematologic cancer	2.3e-06	1.58e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—ALB—hematologic cancer	2.27e-06	1.56e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—PIK3R1—hematologic cancer	2.17e-06	1.49e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—PIK3CB—hematologic cancer	2.15e-06	1.48e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—PIK3CB—hematologic cancer	2.01e-06	1.38e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—PTEN—hematologic cancer	1.86e-06	1.28e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—EP300—hematologic cancer	1.77e-06	1.22e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—PTEN—hematologic cancer	1.73e-06	1.19e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—EP300—hematologic cancer	1.65e-06	1.14e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—PIK3CA—hematologic cancer	1.31e-06	9.01e-06	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—PIK3CA—hematologic cancer	1.22e-06	8.4e-06	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—AKT1—hematologic cancer	1.07e-06	7.36e-06	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—AKT1—hematologic cancer	9.99e-07	6.86e-06	CbGpPWpGaD
